✦ LIBER ✦

Defining risk status in the first-line treatment of metastatic renal cell carcinoma

✍ Scribed by Manuela Schmidinger; Christoph C. Zielinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New challenges and chances in the treatm

✍ Michael Siebels; Dolores Schendel 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 116 KB

Phase II trial of continuous once-daily

✍ Carlos H. Barrios; David Hernandez-Barajas; Michael P. Brown; Se-Hoon Lee; Luis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 855 KB

A pilot study of suramin in the treatmen

✍ Renato V. la Rocca; Cy A. Stein; Romano Danesi; Michael R. Cooper; Margaret Uhri 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

Phase II study of fotemustine as second-

✍ Christine Lassel; Yacine Merrouche; Sylvie Negrier; Paul Rebattu; Jocelyne Beril 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 265 KB

Novel approaches in the therapy of metas

✍ John S. Lam; John T. Leppert; Arie S. Belldegrun; Robert A. Figlin 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 434 KB

Impact of histology on the treatment out

✍ Jingjing Wu; Geralyn Caliendo; Xiao-Ping Hu; Janice P Dutcher 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 405 KB